12 results on '"Sadelain M"'
Search Results
2. Phase I trial of 19-28z chimeric antigen receptor modified T cells (19-28z CAR-T) post-high dose therapy and autologous stem cell transplant (HDT-ASCT) for relapsed and refractory (rel/ref) aggressive B-cell non-Hodgkin lymphoma (B-NHL)
3. Interim safety analysis: A phase I trial of high dose therapy and autologous stem cell transplantation followed by infusion of chimeric antigen receptor modified T-cells (19-28z CAR-T) directed against CD19+B-cells for relapsed and refractory aggressive B cell non-Hodgkin lymphoma (B-NHL)
4. CD19-targeted donor T cells exert potent graft versus lymphoma activity and attenuated GVHD
5. CD19-targeted 19-28z CAR modified autologous T cells induce high rates of complete remission and durable responses in adult patients with relapsed, refractory B-cell ALL
6. T-cell imaging to noninvasively monitor adoptive T-cell therapy for thoracic malignancies
7. Retroviral mediated transfer and expression of the human glucose 6-phosphate dehydrogenase (G6PD) gene in mouse bone marrow cells
8. Optimal activation of both CD28 and 4-1BB in CAR-targeted T cells results in enhanced tumor eradication
9. Genetic treatment of severe hemoglobinopathies: The combat against transgene variegation and transgene silencing
10. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice
11. Therapeutic globin gene delivery using lentiviral vectors
12. Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.